Pembrolizumab: as the comparator
114 studies: what is tested is compared with it. Page 2 of 2. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.
- Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT05502237Phase 3Report a problem
- AK112 in Advanced Non-Small Cell Lung CancerActive, not recruitingNCT05499390Phase 3Report a problem
- Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic MelanomaActive, not recruitingNCT05352672Phase 3Report a problem
- A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 MutationsActive, not recruitingNCT05048797Phase 3Report a problem
- A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)Status unknownNCT04964479Phase 3Report a problem
- HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung CancerStatus unknownNCT04750083Phase 2/3Report a problem
- Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung CancerCompletedNCT04736173Phase 2Report a problem
- NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBCActive, not recruitingNCT04335669Phase 3Report a problem
- Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung CancerStatus unknownNCT04252365Phase 2Report a problem
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab StudyActive, not recruitingNCT03768063Phase 3Report a problem
- A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsActive, not recruitingNCT03530397Phase 1Report a problem
- Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLCStatus unknownNCT03525782Phase 1/2Report a problem
- To Evaluate the Efficacy Beyond Progression of Vemurafenib+Cobimetinib Associated With Local Treatment Compared to Second-line Treatment in Patients With BRAFV600+ Metastatic Melanoma in Focal Progression With First-line+Vemurafenib+Cobimetinib.Status unknownNCT03514901Phase 2Report a problem
- Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475Status unknownNCT02430363Phase 1/2Report a problem